Journal of the American Chemical Society
Article
2b (Methyl 4-(4-methyl-2-oxo-2H-chromen-7-yloxy)-3-nitroben-
Hz, 1H), 6.42 (d, J = 1.6 Hz, 1H), 2.42 (s, 3H), 2.40 (s, 3H); 13C
NMR (100 MHz, DMSO-d6) δ: 159.61, 153.73, 152.97, 151.14,
146.60, 135.68, 133.59, 131.41, 130.77, 128.72, 127.42, 119.17, 118.52,
114.91, 110.70, 21.59, 18.51; mp: 92−95 °C; ESI-MS (m/z): [M +
H]+ 331.2.
1
zoate, Scheme 2). H NMR (400 MHz, DMSO-d6) δ: 8.56 (s, 1H),
8.22 (d, J = 7.2 Hz, 1H), 7.88 (dd, J = 8.8, 4.0 Hz, 1H), 7.36 (dd, J =
8.4, 3.6 Hz, 1H), 7.27 (s, 1H), 7.20 (d, J = 8.0 Hz, 1H), 6.38 (s, 1H),
3.90 (s, 3H), 2.43 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ:
164.51, 159.98, 157.79, 154.73, 153.39, 152.63, 140.91, 135.99, 127.98,
127.39, 126.09, 121.74, 117.29, 115.83, 113.81, 197.51, 53.20, 18.62;
mp: 164−165 °C; ESI-MS(m/z): [M + H]+ 356.3.
3d (4-Methyl-2-oxo-2H-chromen-7-yl-2,4-dinitrobenzenesulfo-
1
nate, Scheme 4). H NMR (400 MHz, DMSO-d6) δ: 9.12 (s, 1H),
8.63 (d, J = 8.0 Hz, 1H), 8.32 (d, J = 8.4 Hz, 1H), 7.85 (d, J = 8.4 Hz,
1H), 7.32 (s, 1H), 7.23 (d, J = 8.0 Hz, 1H), 6.44 (s, 1H), 2.41 (s, 3H);
13C NMR (100 MHz, DMSO-d6) δ: 159.52, 153.92, 152.90, 152.02,
150.37, 148.57, 134.10, 131.01, 128.09, 127.86, 121.69, 119.95, 118.54,
115.35, 110.85, 18.57; mp: 187−188 °C; ESI-MS (m/z): [M + H]+
407.2.
1
2c (7-(4-Nitrophenoxy)-4-methylcoumarin, Scheme 2). H NMR
(400 MHz, CDCl3) δ: 8.29 (d, J = 9.2 Hz, 2H), 7.66 (d, J = 8.0 Hz,
1H), 7.15 (d, J = 9.2 Hz, 2H), 7.04 (d, J = 8.4 Hz, 1H), 7.02 (d, J = 2.4
Hz, 1H), 6.28 (s, 1H), 2.46 (s, 3H); 13C NMR (100 MHz, CDCl3) δ:
161.86, 160.00, 157.79, 154.77, 153.37, 143.47, 127.89, 126.66, 119.01,
117.21, 116.48, 113.72, 108.13, 18.60; mp: 156−158 °C; ESI-MS (m/
z): [M + H]+ 298.3.
5b (4-Trifluoromethyl-2-oxo-2H-chromen-7-yl-2,4-dinitrobenze-
1
nesulfonate, Scheme 4). H NMR (400 MHz, DMSO-d6) δ: 9.12
(s, 1H), 8.64 (t, 1H), 8.35 (d, J = 8.8 Hz, 1H), 7.80 (d, J = 8.4 Hz,
1H),7.54 (s, 1H), 7.32 (t, 1H), 7.16 (s, 1H); 13C NMR (100 MHz,
DMSO-d6) δ: 158.21, 154.99, 152.09, 150.91, 148.54, 134.05, 130.97,
128.18, 127.21, 121.76, 120.50, 119.42, 118.83, 118.77, 113.62, 111.96;
mp: 125−126 °C; ESI-MS (m/z): [M + H]+ 461.2.
2d (4-(4-Methyl-2-oxo-2H-chromen-7-yloxy)-3-nitrobenzoic acid,
Scheme 2). 1H NMR (400 MHz, DMSO-d6) δ: 13.56 (s, 1H), 8.55 (d,
J = 1.6 Hz, 1H), 8.22 (dd, J = 8.8, 2.0 Hz, 1H), 7.87 (d, J = 8.8 Hz,
1H), 7.35 (d, J = 8.8 Hz, 1H), 7.26 (d, J = 2.4 Hz, 1H), 7.20 (dd, J =
8.8, 2.0 Hz, 1H), 6.38 (s, 1H), 2.44 (s, 3H); 13C NMR (100 MHz,
DMSO-d6) δ: 165.57, 160.02, 158.07, 154.75, 153.41, 152.20, 140.97,
136.18, 127.94, 127.64, 127.46, 121.87, 117.15, 115.65, 113.73, 102.27,
18.63; mp: 230−232 °C; ESI-MS (m/z): [M − H]+ 340.1.
2e (7-Phenoxy-4-methylcoumarin, Scheme 2). 1H NMR (400
MHz, CDCl3) δ: 7.56 (d, J = 8.8 Hz, 1H), 7.44 (t, 2H), 7.25 (t, 1H),
7.10 (d, J = 8.0 Hz, 2H), 6.97 (dd, J = 8.8, 2.4 Hz, 1H), 6.87 (d, J = 2.4
Hz, 1H), 6.19 (s, 1H), 2.42 (s, 3H); 13C NMR (100 MHz, CDCl3) δ:
160.56, 160.20, 155.38, 154.80, 153.53, 130.78, 127.52, 125.29, 120.28,
115.47, 114.46, 112.74, 105.33, 18.56; mp: 59−60 °C; ESI-MS (m/z):
[M + H]+ 253.2.
Synthesis of Compound 8 (4-Hydroxy-n-butyl-1,8-naphthali-
mide, Scheme 2). A mixture of 7 (2.08 g, 7.3 mmol), which was
prepared according to the literature from 4-bromo-1,8-naphthalic
anhydride via two steps,54 and 57% (v/v) hydroiodic acid (100 mL)
was refluxed under argon for 10 h. After cooling, the resulting mixture
was filtered, then the crude product was washed with water to afford
yellow-green solid. The crude product was purified by column
chromatography on silica gel to afford compound 8 as a pale yellow
1
solid (0.88 g, yield 45%). H NMR (400 MHz, DMSO-d6) δ: 11.83
(s,1H), 8.54 (dd, J = 8.4, 1.2 Hz, 1H), 8.48 (dd, J = 7.2, 1.2 Hz, 1H),
8.36 (d, J = 8.4 Hz, 1H), 7.78 (d, J = 7.6 Hz, 1H), 7.16 (d, J = 8.4 Hz,
1H), 4.03 (t, 2H), 1.63 (m, 2H), 1.38 (m, 2H), 0.93 (t, 3H); 13C
NMR (100 MHz, DMSO-d6) δ: 163.64, 162.96, 160.20, 133.51,
131.09, 129.16, 128.85, 125.59, 122.36, 121.81, 112.61, 109.94, 29.72,
19.77, 13.68; mp: 165−166 °C. ESI-MS (m/z): [M − H]+ 268.5.
Synthesis of Compound 9 (4-(2,4-Dinitrophenoxy)-n-butyl-1,8-
naphthalimide, Scheme 2).55 2,4-Dinitrofluorobenzene (186 mg, 1.0
mmol), compound 8 (134 mg, 0.5 mmol), and anhydrous potassium
carbonate (414 mg, 3 mmol) were added to a three-necked flask under
Ar atmosphere, and anhydrous DMF (5 mL) was injected into the
reaction flask with a syringe. The mixture was stirred at 80 °C until the
starting material disappeared. The solvent was removed under reduced
pressure, and the resulting residue was purified by chromatography on
1
2f (7-(2-Nitrophenoxy)-4-methylcoumarin, Scheme 2). H NMR
(400 MHz, CDCl3) δ: 8.16 (t, 1H), 7.80 (m, 2H), 7.52 (t, 1H),
7.39(d, J = 8.0 Hz, 1H), 7.04 (t, 2H), 6.33 (s, 1H), 2.41 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ: 160.09, 159.53, 154.74, 153.46, 147.89,
142.01, 135.97, 127.71, 126.45, 123.28, 116.22, 114.29, 113.21, 105.56,
102.57, 18.59; mp: 132−134 °C; ESI-MS(m/z): [M + H]+ 298.3.
5a (7-(2,4-Dinitrophenoxy)-4-trifluoromethylcoumarin, Scheme
2). 1H NMR (400 MHz, DMSO-d6) δ: 8.96 (d, J = 2.8 Hz, 1H), 8.63
(dd, J = 9.2, 2.8 Hz, 1H), 7.92 (dd, J = 8.8, 1.6 Hz, 1H), 7.66 (d, J =
9.2 Hz, 1H), 7.38 (d, J = 2.8 Hz, 1H), 7.36 (d, J = 2.0 Hz, 1H), 6.94 (s,
1H); 13C NMR (100 MHz, DMSO-d6) δ: 158.58, 158.25, 155.82,
153.28, 143.36, 140.83, 130.37, 127.38, 122.54, 122.43, 116.90, 116.80,
110.98, 108.54; mp: 162−163 °C, EI-MS(m/z) (%): 396(M+, 40),
229(33), 167(100).
1
silica gel to give compound 9 (217 mg, yield 50%). H NMR (400
MHz, CDCl3) δ: 8.99 (d, J = 2.8 Hz, 1H), 8.71 (dd, J = 7.6, 1.2 Hz,
1H), 8.60 (d, J = 8.0 Hz, 1H), 8.49 (d, J = 1.2 Hz, 1H), 8.47 (dd, J =
9.2, 2.8 Hz, 1H), 7.87 (m,1H), 7.25 (dd, J = 8.0, 1.2 Hz, 2H), 4.21 (t,
2H), 1.76 (m, 2H), 1.50 (m, 2H), 1.00 (t, 3H); 13C NMR (100 MHz,
CDCl3) δ: 163.66, 163.05, 155.21, 153.90, 143.11, 140.52, 132.34,
131.82, 129.71, 129.26, 127.86, 127.54, 124.06, 122.99, 122.38, 121.05,
120.19, 114.40, 40.30, 30.10, 20.30, 13.79; mp: 179−180 °C. EI-
MS(m/z) (%): 435(M+, 3), 268(100), 44(40).
Synthesis of Compounds 3a−3d and 5b. The substituted
benzenesulfonyl chloride (1.0 mmol) in 5 mL of CH2Cl2 was slowly
added to the solution of compound 1 or 4 (1.2 mmol) and Et3N (200
mg, 2 mmol) in 20 mL of CH2Cl2. The mixture was stirred overnight
at room temperature. After the reaction was completed, the mixture
was extracted with CH2Cl2 and dried with anhydrous Na2SO4. After
removing the solvent under reduced pressure, the residue was purified
by flash column chromatography to give compound 3a−3d and 5b.
3a (4-Methyl-2-oxo-2H-chromen-7-yl-4-nitrobenzenesulfonate,
Synthesis of Compound 11 (7-Hydroxy-3-benzo[d]thiazol-2-
ylcoumarin, Scheme 2). 2,4-Dihydroxybenzaldehyde (345.3 mg, 2.5
mmol) and compound 10 (435.55 mg, 2.55 mmol), which was
prepared according to the literature23,56 from 2-aminobenzenethiol,
were dissolved in 5 mL ethanol, and five drops of piperidine were
added. The mixture was stirred at room temperature overnight. After
filtration, the yellow solid was treated with 10% hydrochloric acid. The
suspended solution was stirred at 130 °C overnight, and the resulting
yellow residue was collected by filtration, washed with water, dried
under reduced vacuum, and then purified by silica gel column
1
Scheme 4). H NMR (400 MHz, DMSO-d6) δ: 8.48 (m, 2H), 8.22
(m, 2H), 7.82 (d, J = 8.8 Hz, 1H), 7.26 (d, J = 2.4 Hz, 1H), 7.14 (dd, J
= 8.8, 2.4 Hz, 1H), 6.45 (d, J = 1.2 Hz, 1H), 2.41 (s, 3H); 13C NMR
(100 MHz, DMSO-d6) δ: 159.59, 153.83, 152.96, 151.61, 150.69,
139.45, 130.55, 127.67, 125.56, 119.60, 118.60, 115.15, 110.92, 18.54;
mp: 184−185 °C; ESI-MS (m/z): [M + H]+ 362.3.
3b (4-Methyl-2-oxo-2H-chromen-7-yl-2-nitrobenzenesulfonate,
1
Scheme 4). H NMR (400 MHz, DMSO-d6) δ: 8.24 (d, J = 8.0 Hz,
1H), 8.11 (d, J = 7.2 Hz, 1H), 8.06 (d, J = 8.0 Hz, 1H), 7.92 (t, 1H),
7.83 (d, J = 8.8 Hz, 1H), 7.26 (s, 1H), 7.17 (d, J = 8.0 Hz, 1H), 6.43
(s, 1H), 2.39 (s, 3H); 13C NMR (100 MHz, DMSO-d6) δ: 159.54,
153.85, 152.92, 150.57, 148.34, 137.76, 133.70, 132.30, 127.76, 126.23,
126.06, 119.72, 118.40, 115.22, 110.78, 18.53; mp: 181−182 °C; ESI-
MS (m/z): [M + H]+ 362.2.
1
chromatography to afford compound 11 (515 mg, yield 70%). H
NMR (400 MHz, DMSO-d6) δ: 11.13 (s, 1H), 9.13 (s, 1H), 8.14 (d, J
= 7.6 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.90 (d, J = 8.4 Hz, 1H), 7.55
(m, 1H), 7.45 (t, 1H), 6.93 (dd, J = 8.8, 2.4 Hz, 1H), 6.86 (d, J = 2.0
Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ: 163.45, 160.38, 159.75,
155.73, 151.95, 142.63, 135.59, 131.90, 126.45, 124.95, 122.14, 122.06,
114.51, 114.43, 111.40, 102.01; mp: >300 °C. ESI-MS (m/z): [M +
H]+ 296.0.
3c (4-Methyl-2-oxo-2H-chromen-7-yl-4-methylbenzenesulfo-
1
nate, Scheme 4). H NMR (400 MHz, DMSO-d6) δ: 7.80(t, 3H),
7.50 (d, J = 8.0 Hz, 2H), 7.13 (d, J = 2.4 Hz, 1H), 7.07 (dd, J = 8.8, 2.4
J
J. Am. Chem. Soc. XXXX, XXX, XXX−XXX